🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study seeks to show whether there is a benefit of prescribing Enstilar...
Status
Completed
Location
DermResearch, PLLC
Start Date
2017-12-12
Trial ID
NCT03848871
Treatments Being Tested
Evaluation of safety, pharmacokinetics, and anti-psoriatic efficacy to asse...
Status
Completed
Location
DermResearch, Inc.
Start Date
2016-08
Trial ID
NCT03004339
This will be a single-center, randomized, double-blinded, vehicle-controlle...
Status
Completed
Location
Mount Sinai West
Start Date
2018-05-21
Trial ID
NCT03506477
Treatments Being Tested
To explore the efficacy and safety of four BAY1003803 formulations by means...
Status
Completed
Location
Multiple Locations
Start Date
2016-10-12
Trial ID
NCT02940002
Treatments Being Tested
Patients will be included in a randomized controlled clinical trial, will e...
Status
Unknown
Location
Diala Alshiyab
Start Date
2020-06-21
Trial ID
NCT04440371
The purpose of the study is to investigate if combined use of OLUX-E™ Foam ...
Status
Completed
Location
DermResearch, PLLC
Start Date
2013-01
Trial ID
NCT01745133
Treatments Being Tested
The aim of this study is to understand which therapies will suppress effect...
Status
Completed
Location
Burnside House
Start Date
2010-06
Trial ID
NCT01233583
Treatments Being Tested
Comparison of the efficacy of LEO 90100 foam with Dovobet® ointment in the ...
Status
Completed
Location
Leo Pharma Investigational Site
Start Date
2019-01-24
Trial ID
NCT03806790
Treatments Being Tested
Patients receiving biologic therapy with 5% or less body surface area will ...
Status
Completed
Location
Psoriasis Treatment Center of Central New Jersey
Start Date
2017-05-01
Trial ID
NCT03080545
Treatments Being Tested
This is a phase III, randomized, double-blind, placebo-controlled, parallel...
Status
Completed
Location
Investigational Site 24
Start Date
2017-10-20
Trial ID
NCT03331523
Treatments Being Tested